Stock CTGL CITRINE GLOBAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Citrine Global Corp.

Equities

CTGL

US17737V1052

Market Closed - OTC Markets
Other stock markets
 18:25:40 02/07/2024 BST 		5-day change 1st Jan Change
0.0022 USD -71.76% Intraday chart for Citrine Global Corp. -76.84% -89.00%
02-23 Citrine Global Corp. Announces Resignation of Mr. Doron Birger from the Board CI
02-09 Citrine Global Corp. announced that it has received $0.055 million in funding CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Citrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements’ Company with Fast-Growing Potential
AQ
CITRINE GLOBAL, CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
CITRINE GLOBAL, CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
CITRINE GLOBAL, CORP. : Entry into a Material Definitive Agreement (form 8-K)
AQ
CITRINE GLOBAL, CORP. : Change in Directors or Principal Officers (form 8-K)
AQ
CITRINE GLOBAL, CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
CITRINE GLOBAL, CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Citrine Global Corp. (CTGL) Signs MOU with MyPlant Bio, Specialized in Botanical Drug Development, to Acquire 55% of MyPlant’s Shares against Citrine Global Shares
AQ
CITRINE GLOBAL, CORP. : Other Events (form 8-K)
AQ
Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects
GL
CITRINE GLOBAL, CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
CITRINE GLOBAL, CORP. : Change in Directors or Principal Officers (form 8-K)
AQ
CITRINE GLOBAL, CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)
AQ
CITRINE GLOBAL, CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
CITRINE GLOBAL, CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)
AQ
Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle
AQ
Citrine Global Corp. (OTCQB: CTGL) Announces Prof. Itamar Grotto, a World-Renowned Expert in Public Health, Joining the Company’s Israeli Subsidiary Board of Directors, and Appointed as President of Green Vision Center Israel
AQ
CITRINE GLOBAL, CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Citrine Global : CEO Issues Letter to Shareholders - Form 8-K
PU
Citrine Global CEO Issues Letter to Shareholders
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTGL Stock
  4. News Citrine Global Corp.
  5. Press Releases